Plunkett, W. “Rationale for the Design of Combination Therapies That Are Active in T-Cell Lymphomas?”. Hematology Meeting Reports (formerly Haematologica Reports) 2, no. 13 (June 10, 2009). Accessed May 18, 2024. https://www.pagepress.org/journals/hmr/article/view/498.